ArticleAnnals of hematology2026

Zanubrutinib potentiates polatuzumab vedotin efficacy in DLBCL with concurrent CD79b upregulation.

Xiaolong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.